Olanzapine augmentation of fluoxetine in body dysmorphic disorder

Am J Psychiatry. 2005 May;162(5):1022-3. doi: 10.1176/appi.ajp.162.5.1022-a.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / therapeutic use*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Fluoxetine / therapeutic use*
  • Humans
  • Male
  • Olanzapine
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Somatoform Disorders / drug therapy*
  • Somatoform Disorders / psychology
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Benzodiazepines
  • Olanzapine